Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis (NASH)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04232293
What this trial is testing

Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2NAFLDNASH
Nantes University Hospital 722
Not applicableStudy completedNCT02513121
What this trial is testing

Dietary Treatment Study of Pediatric NAFLD

Who this might be right for
Nonalcoholic Fatty Liver Disease
University of California, San Diego 40
Not applicableUnknownNCT02792634
What this trial is testing

Pathogenesis of Non-alcoholic Steatohepatitis and Liver Regeneration After Bariatric Surgery

Who this might be right for
Bariatric Surgery CandidateNonalcoholic SteatohepatitisObesity
RWTH Aachen University 200
Not applicableStudy completedNCT02363309
What this trial is testing

Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Fatty Liver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 74
Not applicableStudy completedNCT00940537
What this trial is testing

Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Liver Diseases
Washington University School of Medicine 14
Testing effectiveness (Phase 2)Looking for participantsNCT05519475
What this trial is testing

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Who this might be right for
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Regeneron Pharmaceuticals 120
Not applicableUnknownNCT02721264
What this trial is testing

Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis.

Who this might be right for
Non Alcoholic Steatohepatitis
Institute of Liver and Biliary Sciences, India 112
Not applicableStudy completedNCT02690792
What this trial is testing

Effect of Vitamin E on Non-Alcoholic Fatty Liver Disease

Who this might be right for
HealthyNAFLD (Non-Alcoholic Fatty Liver Disease)NASH (Non-Alcoholic Steatohepatitis)
Jeffrey Browning 70
Post-approval studies (Phase 4)Study completedNCT03796975
What this trial is testing

Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes MellitusNon-alcoholic Fatty Liver DiseaseEfficacy
Xijing Hospital 120
Testing effectiveness (Phase 2)Study completedNCT01482065
What this trial is testing

The Sleep, Liver Evaluation and Effective Pressure Study

Who this might be right for
Non Alcoholic Fatty Liver DiseaseObstructive Sleep Apnea
Johns Hopkins University 40
Testing effectiveness (Phase 2)Study completedNCT03656744
What this trial is testing

HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Fatty Liver, NonalcoholicNAFLDNonalcoholic Fatty Liver Disease+3 more
HighTide Therapeutics (Hong Kong) Limited 101
Not applicableStudy completedNCT07294963
What this trial is testing

Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNeurocognitive Disorders
Khyber Medical University Peshawar 45
Not applicableUnknownNCT04653311
What this trial is testing

Evaluation of an Endoscopic Sutured Gastroplasty in Patients With NonAlcoholic Steatohepatitis (NASH) and Fibrosis.

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Erasme University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT02784444
What this trial is testing

Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH

Who this might be right for
Non-alcoholic Fatty Liver DiseaseNon-alcoholic SteatohepatitisNASH - Nonalcoholic Steatohepatitis
Cirius Therapeutics, Inc. 392
Not applicableStudy completedNCT02828579
What this trial is testing

The Impact of Bariatric Surgery on Non-alcoholic Fatty Liver Disease

Who this might be right for
ObesityNAFLD
Jagiellonian University 20
Not applicableStudy completedNCT03518294
What this trial is testing

NASH Fitness Intervention in Thrombosis Trial (NASHFit)

Who this might be right for
Liver DiseasesBlood DisorderDigestive System Disease
Milton S. Hershey Medical Center 28
Not applicableStudy completedNCT03276039
What this trial is testing

Serum Pentraxin-3 in Non-alcoholic Fatty Liver Disease With or Without Hepatitis C Virus

Who this might be right for
Non Alcoholic Fatty Liver Disease
Ain Shams University 70
Not applicableStudy completedNCT04561895
What this trial is testing

Adipokine Genetic Variations in predictingNAFLD Progression to NASH in Egyptian Patients

Who this might be right for
NAFLDNASH - Nonalcoholic Steatohepatitis
Cairo University 224
Early research (Phase 1)UnknownNCT02469272
What this trial is testing

Fecal Microbiota Transplantation (FMT) in Nonalcoholic Steatohepatitis(NASH). A Pilot Study

Who this might be right for
Nonalcoholic Fatty Liver Disease
Lifespan 5
Post-approval studies (Phase 4)Study completedNCT02285205
What this trial is testing

A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLD

Who this might be right for
Type 2 DiabetesNon-alcoholic Fatty Liver Disease
Yonsei University 38
Next Page